Cargando…
Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149162/ https://www.ncbi.nlm.nih.gov/pubmed/34048824 http://dx.doi.org/10.1016/j.kint.2021.05.007 |
| _version_ | 1783697904375955456 |
|---|---|
| author | Holzworth, Amy Couchot, Patrick Cruz-Knight, Wanda Brucculeri, Michael |
| author_facet | Holzworth, Amy Couchot, Patrick Cruz-Knight, Wanda Brucculeri, Michael |
| author_sort | Holzworth, Amy |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8149162 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | International Society of Nephrology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81491622021-05-26 Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine Holzworth, Amy Couchot, Patrick Cruz-Knight, Wanda Brucculeri, Michael Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-08 2021-05-26 /pmc/articles/PMC8149162/ /pubmed/34048824 http://dx.doi.org/10.1016/j.kint.2021.05.007 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Holzworth, Amy Couchot, Patrick Cruz-Knight, Wanda Brucculeri, Michael Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine |
| title | Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine |
| title_full | Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine |
| title_fullStr | Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine |
| title_full_unstemmed | Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine |
| title_short | Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine |
| title_sort | minimal change disease following the moderna mrna-1273 sars-cov-2 vaccine |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149162/ https://www.ncbi.nlm.nih.gov/pubmed/34048824 http://dx.doi.org/10.1016/j.kint.2021.05.007 |
| work_keys_str_mv | AT holzworthamy minimalchangediseasefollowingthemodernamrna1273sarscov2vaccine AT couchotpatrick minimalchangediseasefollowingthemodernamrna1273sarscov2vaccine AT cruzknightwanda minimalchangediseasefollowingthemodernamrna1273sarscov2vaccine AT brucculerimichael minimalchangediseasefollowingthemodernamrna1273sarscov2vaccine |